264 related articles for article (PubMed ID: 25411382)
1. Physiological activation of Akt by PHLPP1 deletion protects against pathological hypertrophy.
Moc C; Taylor AE; Chesini GP; Zambrano CM; Barlow MS; Zhang X; Gustafsson ÅB; Purcell NH
Cardiovasc Res; 2015 Feb; 105(2):160-70. PubMed ID: 25411382
[TBL] [Abstract][Full Text] [Related]
2. PHLPP-1 negatively regulates Akt activity and survival in the heart.
Miyamoto S; Purcell NH; Smith JM; Gao T; Whittaker R; Huang K; Castillo R; Glembotski CC; Sussman MA; Newton AC; Brown JH
Circ Res; 2010 Aug; 107(4):476-84. PubMed ID: 20576936
[TBL] [Abstract][Full Text] [Related]
3. PHLPP1 gene deletion protects the brain from ischemic injury.
Chen B; Van Winkle JA; Lyden PD; Brown JH; Purcell NH
J Cereb Blood Flow Metab; 2013 Feb; 33(2):196-204. PubMed ID: 23072745
[TBL] [Abstract][Full Text] [Related]
4. PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum.
Saavedra A; García-Martínez JM; Xifró X; Giralt A; Torres-Peraza JF; Canals JM; Díaz-Hernández M; Lucas JJ; Alberch J; Pérez-Navarro E
Cell Death Differ; 2010 Feb; 17(2):324-35. PubMed ID: 19745829
[TBL] [Abstract][Full Text] [Related]
5. Akt activation by PHLPP1 ablation prevents pathological hypertrophy by promoting angiogenesis.
Li M; Hirsch E
Cardiovasc Res; 2015 Feb; 105(2):129-30. PubMed ID: 25538154
[No Abstract] [Full Text] [Related]
6. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 3 suppression increases PH domain and leucine-rich repeat phosphatase (Phlpp)1 expression in chondrocytes to suppress Akt signaling and matrix secretion.
Bradley EW; Carpio LR; Westendorf JJ
J Biol Chem; 2013 Apr; 288(14):9572-9582. PubMed ID: 23408427
[TBL] [Abstract][Full Text] [Related]
8. Deletion of the PH-domain and Leucine-rich Repeat Protein Phosphatase 1 (Phlpp1) Increases Fibroblast Growth Factor (Fgf) 18 Expression and Promotes Chondrocyte Proliferation.
Bradley EW; Carpio LR; Newton AC; Westendorf JJ
J Biol Chem; 2015 Jun; 290(26):16272-80. PubMed ID: 25953896
[TBL] [Abstract][Full Text] [Related]
9. Mutual inhibition of insulin signaling and PHLPP-1 determines cardioprotective efficiency of Akt in aged heart.
Xing Y; Sun W; Wang Y; Gao F; Ma H
Aging (Albany NY); 2016 May; 8(5):873-88. PubMed ID: 27019292
[TBL] [Abstract][Full Text] [Related]
10. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
[TBL] [Abstract][Full Text] [Related]
11. PHLPPing through history: a decade in the life of PHLPP phosphatases.
Grzechnik AT; Newton AC
Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677
[TBL] [Abstract][Full Text] [Related]
12. Increased cardiac remodeling in cardiac-specific Flt-1 receptor knockout mice with pressure overload.
Mei L; Huang Y; Lin J; Chu M; Hu C; Zhou N; Wu L
Cell Tissue Res; 2015 Nov; 362(2):389-98. PubMed ID: 26017635
[TBL] [Abstract][Full Text] [Related]
13. In vivo cardiac role of migfilin during experimental pressure overload.
Haubner BJ; Moik D; Schuetz T; Reiner MF; Voelkl JG; Streil K; Bader K; Zhao L; Scheu C; Mair J; Pachinger O; Metzler B
Cardiovasc Res; 2015 Jun; 106(3):398-407. PubMed ID: 25852081
[TBL] [Abstract][Full Text] [Related]
14. Photoreceptor Neuroprotection: Regulation of Akt Activation Through Serine/Threonine Phosphatases, PHLPP and PHLPPL.
Rajala RV; Kanan Y; Anderson RE
Adv Exp Med Biol; 2016; 854():419-24. PubMed ID: 26427440
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance.
Andreozzi F; Procopio C; Greco A; Mannino GC; Miele C; Raciti GA; Iadicicco C; Beguinot F; Pontiroli AE; Hribal ML; Folli F; Sesti G
Diabetologia; 2011 Jul; 54(7):1879-87. PubMed ID: 21461637
[TBL] [Abstract][Full Text] [Related]
16. On the PHLPPside: Emerging roles of PHLPP phosphatases in the heart.
Lemoine KA; Fassas JM; Ohannesian SH; Purcell NH
Cell Signal; 2021 Oct; 86():110097. PubMed ID: 34320369
[TBL] [Abstract][Full Text] [Related]
17. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
[TBL] [Abstract][Full Text] [Related]
18. Exploitation of the ability of γ-tocopherol to facilitate membrane co-localization of Akt and PHLPP1 to develop PHLPP1-targeted Akt inhibitors.
Yan R; Chuang HC; Kapuriya N; Chou CC; Lai PT; Chang HW; Yang CN; Kulp SK; Chen CS
J Med Chem; 2015 Mar; 58(5):2290-8. PubMed ID: 25689347
[TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
20. The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.
Nitsche C; Edderkaoui M; Moore RM; Eibl G; Kasahara N; Treger J; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS
Gastroenterology; 2012 Feb; 142(2):377-87.e1-5. PubMed ID: 22044669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]